During the last session, Prothena Corporation plc (NASDAQ:PRTA)’s traded shares were 0.47 million, with the beta value of the company hitting 0.07. At the end of the trading day, the stock’s price was $14.60, reflecting an intraday gain of 1.11% or $0.16. The 52-week high for the PRTA share is $41.54, that puts it down -184.52 from that peak though still a striking 9.45% gain since the share price plummeted to a 52-week low of $13.22. The company’s market capitalization is $785.61M, and the average intraday trading volume over the past 10 days was 0.47 million shares, and the average trade volume was 485.21K shares over the past three months.
Prothena Corporation plc (PRTA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.50. PRTA has a Sell rating from 1 analyst(s) out of 15 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 11 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -1.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Prothena Corporation plc (NASDAQ:PRTA) trade information
Prothena Corporation plc (PRTA) registered a 1.11% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.11% in intraday trading to $14.60, hitting a weekly high. The stock’s 5-day price performance is 4.21%, and it has moved by -10.26% in 30 days. Based on these gigs, the overall price performance for the year is -55.39%. The short interest in Prothena Corporation plc (NASDAQ:PRTA) is 7.53 million shares and it means that shorts have 11.21 day(s) to cover.
The consensus price target of analysts on Wall Street is $56, which implies an increase of 73.93% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $24 and $98 respectively. As a result, PRTA is trading at a discount of -571.23% off the target high and -64.38% off the low.
Prothena Corporation plc (PRTA) estimates and forecasts
Statistics show that Prothena Corporation plc has outperformed its competitors in share price, compared to the industry in which it operates. Prothena Corporation plc (PRTA) shares have gone down -27.15% during the last six months, with a year-to-date growth rate more than the industry average at 18.48% against 17.90. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 20.98% this quarter and then jump 4.48% in the quarter after that. In the rating firms’ projections, revenue will increase 54.73% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 8.35M as predicted by 8 analyst(s). As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 316k and 50k respectively. In this case, analysts expect current quarter sales to grow by 2,542.37% and then drop by -100.00% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 6.83%. While earnings are projected to return 20.56% in 2024, the next five years will return 34.07% per annum.
PRTA Dividends
Prothena Corporation plc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Prothena Corporation plc (NASDAQ:PRTA)’s Major holders
Prothena Corporation plc insiders own 12.47% of total outstanding shares while institutional holders control 96.60%, with the float percentage being 110.36%. ECOR1 CAPITAL, LLC is the largest shareholder of the company, while 247.0 institutions own stock in it. As of 2024-06-30, the company held over 11.58 million shares (or 21.5666% of all shares), a total value of $239.1 million in shares.
The next largest institutional holding, with 8.07 million shares, is of FMR LLC’s that is approximately 15.016% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $166.48 million.
Also, the Mutual Funds coming in first place with the largest holdings of Prothena Corporation plc (PRTA) shares are Vanguard Specialized-Health Care Fund and Fidelity Growth Company Fund . Data provided on Jul 31, 2024 indicates that Vanguard Specialized-Health Care Fund owns about 3.01 shares. This amounts to just over 5.59 percent of the company’s overall shares, with a $43.91 million market value. The same data shows that the other fund manager holds slightly less at 2.35, or about 4.38% of the stock, which is worth about $34.38 million.
